Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aptevo Therapeutics Inc (APVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aptevo Therapeutics Inc 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 USA

P: 206-838-0500 F: 206-838-0503

Description:

Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 106,851
Shares Outstanding, K 22,590
Annual Sales, $ 14,660 K
Annual Net Income, $ 6,970 K
Last Quarter Sales, $ 4,070 K
Last Quarter Net Income, $ -13,850 K
36-Month Beta 0.74
% of Insider Shareholders 18.00%
% of Institutional Shareholders 34.16%

Growth:

1-Year Total Return 187.21%
3-Year Total Return 0.00%
5-Year Total Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/09/18
Earnings Per Share ttm -1.02
EPS Growth vs. Prev Year -31.25%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

APVO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.80
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -47.64
Return-on-Assets (Before Tax) -31.98
Net Margin % N/A
Debt/Equity 0.20
Price/Sales 7.30
Price/Cash Flow N/A
Price/Book 1.56
Book Value/Share 3.05
Interest Coverage N/A
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar